Eli Lilly’s Zepbound bested Novo Nordisk’s Wegovy in the first head-to-head trial comparing weight loss outcomes for people with obesity or overweight, according to top-line results shared by Lilly last week.
Since it was approved for weight management in late 2023, Zepbound users have…
Zepbound Helps People Shed More Weight Than Wegovy, According to Eli Lilly Trial …C0NTINUE READING >>>>